Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BioRestorative Therapies, Inc. | Chief Financial Officer | Common Stock | 7.99K | $10.6K | $1.32 | Feb 13, 2024 | Direct |
BioRestorative Therapies, Inc. | Chief Financial Officer | Stock Option | 263K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BRTX | BioRestorative Therapies, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Feb 17, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Nov 3, 2022 | 2 | $0 | 4 | Nov 4, 2022 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Jun 15, 2022 | 1 | $700 | 4 | Jun 15, 2022 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Jun 7, 2022 | 1 | $912 | 4 | Jun 7, 2022 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Apr 8, 2022 | 1 | $43.4K | 4 | Apr 11, 2022 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Nov 4, 2021 | 1 | $0 | 4 | Nov 16, 2021 | Chief Financial Officer |
BRTX | BioRestorative Therapies, Inc. | Nov 4, 2021 | 0 | $0 | 3 | Nov 16, 2021 | Chief Financial Officer |